Vajihe Akbari

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Circulating Tumor

Epidermal Growth Factor Receptor

Top Venues

Biotechnology letters

Biotechnology progress

International journal of toxicology

Biotechnology and applied biochemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Zahra Shariaty Vaziri, Fatemeh Shafiee, Vajihe Akbari
Design and construction of scFv-PE35KDEL as a novel immunotoxin against human epidermal growth factor receptor 2 for cancer therapy. Biotechnology letters (2023)
Zahra Shariaty Vaziri, Fatemeh Shafiee, Vajihe Akbari
Design and construction of scFv-PE35KDEL as a novel immunotoxin against human epidermal growth factor receptor 2 for cancer therapy. Biotechnology letters 45 (4) (2023)
Ghazale Minaiyan, Fatemeh Shafiee, Vajihe Akbari
Survivin Promoter-Driven DFF40 Gene Expression Sensitizes Melanoma Cancer Cells to Chemotherapy. International journal of toxicology 40 (4) (2021)
Zahra Malekpour, Vajihe Akbari, Jaleh Varshosaz, Azade Taheri
Preparation and characterization of poly (lactic-co-glycolic acid) nanofibers containing simvastatin coated with hyaluronic acid for using in periodontal tissue engineering. Biotechnology progress (2021)
Vajihe Akbari, Mahboubeh Rezazadeh, Narges Seyed Hanaie, Farshid Hasanzadeh
Preparation and in vitro characterization of histidine trimethyl chitosan conjugated nanocomplex incorporated into injectable thermosensitive hydrogels for localized gene delivery. Biotechnology and applied biochemistry (2021)